Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do heavy smokers benefit from higher dose nicotine patch therapy?

J D Killen1, S P Fortmann, L Davis

  • 1Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304-1825, USA. killen@scrdp.stanford.edu

Experimental and Clinical Psychopharmacology
|September 3, 1999
PubMed
Summary

This study found that a higher dose (25 mg) nicotine patch did not significantly improve smoking cessation rates compared to a standard dose (15 mg) for heavy smokers. Both doses were well-tolerated, with similar adverse events reported.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does smoking cessation improve health-related quality-of-life?

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2013
Same author

Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation.

Transplantation proceedings·2003
Same author

Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation.

Transplantation proceedings·2003
Same author

The relationship between agoraphobia symptoms and panic disorder in a non-clinical sample of adolescents.

Psychological medicine·2003
Same author

Effect of Withania somnifera on cell mediated immune responses in mice.

Journal of experimental & clinical cancer research : CR·2003
Same author

Augmentation of coronary conductance in adult sheep made anaemic during fetal life.

The Journal of physiology·2003

Area of Science:

  • Addiction Medicine
  • Pharmacology
  • Clinical Trials

Background:

  • Nicotine dependence is a significant public health issue.
  • Nicotine replacement therapy (NRT) is a common smoking cessation aid.
  • Optimizing NRT dosage for heavy smokers requires further investigation.

Purpose of the Study:

  • To compare the efficacy of high-dose (25 mg) versus standard-dose (15 mg) nicotine patch therapy for smoking cessation in heavy smokers.
  • To assess the safety and tolerability of different nicotine patch doses.
  • To identify predictors of relapse in smoking cessation.

Main Methods:

  • Randomized controlled trial involving 408 heavy smokers (≥25 cigarettes/day).
  • Participants received either 15 mg or 25 mg nicotine patch therapy for 16 hours/day over 6 weeks.

Related Experiment Videos

  • Follow-up assessments at 2, 6, and 12 months to determine smoking status.
  • Cox proportional hazards analyses were used to identify relapse predictors.

    • Main Results:

    • Smoking cessation rates were similar between the 15-mg and 25-mg nicotine patch groups at all follow-up points (2, 6, and 12 months).
    • The higher dose nicotine patch was well-tolerated, with comparable adverse event profiles to the standard dose.
    • Initial postrandomization craving and baseline depression scores predicted time-to-relapse during treatment, while only initial craving predicted relapse over 12 months.

    Conclusions:

    • Higher-dose (25 mg) nicotine patch therapy does not offer superior smoking cessation efficacy compared to standard-dose (15 mg) therapy for heavy smokers.
    • Routine use of higher-dose nicotine patch therapy is not supported by these findings.
    • Craving is a significant predictor of relapse in smoking cessation interventions.